Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 358.85
+7.10 (2.02%)
At close: Jul 31, 2026
Gujarat Themis Biosyn Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,658 | 1,658 | 1,508 | 1,698 | 1,484 | 1,149 |
Revenue Growth | 9.96% | 9.96% | -11.20% | 14.45% | 29.20% | 26.82% |
Gross Profit Gross Profit Growth | 1,075 | 1,075 | 914.8 | 1,011 | 910.46 | 967.29 |
Operating Income Operating Income Growth | 626.11 | 626.11 | 643.33 | 751.75 | 719.25 | 565.33 |
Net Income Net Income Growth | 466.82 | 466.82 | 487.72 | 591.63 | 579.69 | 436.24 |
Earnings Per Share EPS Growth | 4.28 | 4.28 | 4.48 | 5.43 | 5.32 | 4.00 |
EPS Growth | -4.38% | -4.38% | -17.56% | 2.06% | 32.88% | 44.57% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 60.88 | 60.88 | 116.94 | 141.28 | 89.03 | 218.4 |
Total Debt Total Debt Growth | 1,618 | 1,618 | 304.7 | 27.68 | 4.19 | 11.69 |
Net Cash (Debt) Net Cash Growth | -1,557 | -1,557 | -187.76 | 113.59 | 84.84 | 206.7 |
Net Cash Growth | - | - | - | 33.89% | -58.96% | -41.56% |
Net Cash Per Share Net Cash Per Share Growth | -14.28 | -14.28 | -1.72 | 1.04 | 0.78 | 1.90 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 487.77 | 487.77 | 910.29 | 642.13 | 394.76 | 403.13 |
Capital Expenditures CapEx Growth | -1,725 | -1,725 | -1,162 | -746.45 | -237.02 | -138.98 |
Free Cash Flow Free Cash Flow Growth | -1,238 | -1,238 | -251.22 | -104.32 | 157.74 | 264.16 |
Free Cash Flow Growth | - | - | - | - | -40.28% | 253.47% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 64.85% | 64.85% | 60.66% | 59.52% | 61.36% | 84.22% |
Operating Margin | 37.76% | 37.76% | 42.66% | 44.27% | 48.47% | 49.22% |
Pretax Margin | 37.44% | 37.44% | 43.46% | 46.72% | 52.21% | 51.40% |
Profit Margin | 28.15% | 28.15% | 32.34% | 34.84% | 39.07% | 37.98% |
FCF Margin | -74.63% | -74.63% | -16.66% | -6.14% | 10.63% | 23.00% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.670 | 0.670 | 0.670 | 1.000 | 0.720 | 0.800 |
Dividend Per Share Growth | 0.50% | 0% | -33.00% | 38.89% | -10.00% | - |
Dividend Yield | 0.19% | 0.29% | 0.24% | 0.38% | 0.79% | 1.50% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 83.84 | 53.09 | 62.89 | 48.64 | 17.20 | 13.57 |
P/FCF Ratio | - | - | - | - | 63.22 | 22.41 |
PS Ratio | 23.58 | 14.95 | 20.34 | 16.94 | 6.72 | 5.15 |